The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
The orphan nuclear receptor SHP acts as a negative regulator in inflammatory signaling triggered by Toll-like receptors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · cited 1×
“An important downstream adaptor for members of the IRAK family, TRAF6 catalyzes the attachment of Lys63 (K63)-linked polyubiquitin chains to both TRAF6 itself and the NF-κB modulator IKKγ (NEMO”
BackgroundToll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738 · cited 1×
“2064" language="eng" relation="no"> Sepsis is a leading cause of death worldwide and is manifested by harmful and damaging overproduction of proinflammatory cytokine”
BackgroundDeng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
Negative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509 · cited 1×
“TLR signaling pathways are tightly controlled to prevent excessive activation of the TLR pathway and pathogenic inflammatio”
BackgroundUbiquitin signalling in the NF-κB pathway
Chen, Z. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-758 · Cited by 1,184
TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response
Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. A., & Lemke, G. (2007) · Cell · doi:10.1016/j.cell.2007.10.034 · Cited by 1,055 · cited 1×
“Many TLR signaling pathways are controlled by molecules such as the TAM receptors, which are a group of three receptor tyrosine kinases (TYRO3, AXL and MER”
BackgroundDe Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
Cited by
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
Post-Translational Modification Control of Innate Immunity
Liu, J., Qian, C., & Cao, X. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.020 · Cited by 633
Host innate immune responses to sepsis
Wiersinga, W. J., Leopold, S. J., Cranendonk, D. R., & van der Poll, T. (2014) · Virulence · doi:10.4161/viru.25436 · Cited by 460
Dissecting negative regulation of Toll-like receptor signaling
Kondo, T., Kawai, T., & Akira, S. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.05.002 · Cited by 419
Calcium/Calmodulin-dependent Protein Kinase Kinase 2: Roles in Signaling and Pathophysiology
Racioppi, L., & Means, A. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.356485 · Cited by 284
Recent clinical trends in Toll‐like receptor targeting therapeutics
Anwar, M. A., Shah, M., Kim, J., & Choi, S. (2019) · Medicinal Research Reviews · doi:10.1002/med.21553 · Cited by 275
Self-citationKumar, V. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107087 · Cited by 272
Bile acids and their receptors in metabolic disorders
Fiorucci, S., Distrutti, E., Carino, A., Zampella, A., & Biagioli, M. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101094 · Cited by 258
Bile acids activated receptors in inflammatory bowel disease
Biagioli, M., Marchianò, S., Carino, A., Di Giorgio, C., Santucci, L., Distrutti, E., & Fiorucci, S. (2021) · Cells · doi:10.3390/cells10061281 · Cited by 103
“In addition to these mechanisms, SHP has been shown to prevent NLRP3 formation [51,52] (Figure 2A).”
BackgroundMurphy, E., & Crean, D. (2015) · Biomolecules · doi:10.3390/biom5031302 · Cited by 82
“Recently, using murine macrophages, the orphan nuclear receptor small heterodimer partner (SHP) has been shown to inhibit NF- B activity at multiple stages of its pathway [29].”
BackgroundKim, E., Beon, J., Lee, S., Park, S. J., Ahn, H., Kim, M. G., Park, J. E., Kim, W., Yuk, J.-M., Kang, S.-J., et al. (2017) · Science Advances · doi:10.1126/sciadv.1602296 · Cited by 50
Self-citationKim, J. H., Lee, J., Bae, S.-J., Kim, Y., Park, B.-J., Choi, J.-W., Kwon, J., Cha, G.-H., Yoo, H. J., Jo, E.-K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06610-4 · Cited by 45
Self-citationNuclear receptors, cholesterol homeostasis and the immune system
Shahoei, S. H., & Nelson, E. R. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.013 · Cited by 43
Lee, J. H., Kim, H., Park, S. J., Woo, J. H., Joe, E.-H., & Jou, I. (2016) · Science Signaling · doi:10.1126/scisignal.aaf4850 · Cited by 24
Small Heterodimer Partner Regulates Dichotomous T Cell Expansion by Macrophages
Shahoei, S. H., Kim, Y.-C., Cler, S. J., Ma, L., Anakk, S., Kemper, J. K., & Nelson, E. R. (2019) · Endocrinology · doi:10.1210/en.2019-00025 · Cited by 16
Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells
Vidana Gamage, H. E., Albright, S. T., Smith, A. J., Farmer, R., Shahoei, S. H., Wang, Y., Fink, E. C., Jacquin, E., Weisser, E., Bautista, R. O., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217086 · Cited by 13
Vidana Gamage, H. E., Shahoei, S. H., Wang, Y., Jacquin, E., Weisser, E., Bautista, R. O., Henn, M. A., Schane, C. P., Nelczyk, A. T., Ma, L., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217042 · Cited by 9
“Mice with a whole-body knockout of NR0B2 were protected from septic shock induced by LPS [67].”
Wang, Y., Bendre, S. V., Krauklis, S. A., Steelman, A. J., & Nelson, E. R. (2025) · Endocrinology · doi:10.1210/endocr/bqaf031 · Cited by 6
Metadata
- Authors
- Yuk, J.-M., Shin, D.-M., Lee, H.-M., Kim, J.-J., Kim, S.-W., Jin, H. S., Yang, C.-S., Park, K. A., Chanda, D., Kim, D.-K., Huang, S. M., Lee, S. K., Lee, C.-H., Kim, J.-M., Song, C.-H., Lee, S. Y., Hur, G. M., Moore, D. D., Choi, H.-S., & Jo, E.-K.
- Venue
- Nature Immunology
- Published
- 2011-07-03
- Volume
- 12
- Issue
- 8
- Pages
- 742-751
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2082861881
- Cited by
- 188
- References
- 11
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.